SEC Filing Summary: Global Medical REIT Inc. (GMRE)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Global Medical REIT Inc. on June 6, 2022. The filing serves as a Regulation FD disclosure regarding an updated investor presentation posted to the company's website on the same date. The registrant is incorporated in Maryland and trades on the NYSE under the symbols GMRE (Common Stock) and GMRE PrA (Series A Preferred Stock).
Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural disclosure referencing an external presentation (Exhibit 99.1) rather than a financial statement filing.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The sole reported event is the update of the investor presentation materials available to the public.
Guidance, Outlook, and Risks
The filing explicitly states that the investor presentation (Exhibit 99.1) is furnished for informational purposes only and is not deemed "filed" under the Securities Exchange Act of 1934. Consequently, the information within the presentation is not subject to the liabilities of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings. No specific guidance, outlook, or risk factors are enumerated in the body of this 8-K.
Key Facts for Investor Verification
- Verify the content of the investor presentation dated June 6, 2022, by reviewing Exhibit 99.1 directly on the SEC EDGAR database or the company's website.
- Note that the presentation is not legally "filed" and does not carry the same liability protections as standard SEC filings.
- Confirm the company's current status as a non-emerging growth company based on the checkmarks in the filing.
- Review the company's principal executive office address at 2 Bethesda Metro Center, Suite 440, Bethesda, MD 20814.